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the remaining 27% who never returned to pre-hosp ESA dose, an additional
266K U of epoetin were utilized.
The majority of hospitalizations (2/3) had considerable post-hosp Hb
drops (mean 41 g/dL), with 450% permanently reduced. 1.5 months
were needed to recover Hb, with elevated ESA doses for 42 months. ESA
dose was permanently elevated in 27% of hospitalizations that recovered
Hb. Strategies to address post-hosp anemia may mitigate the protracted
recovery time and increased ESA use.
http://dx.doi.org/10.1016/j.krcp.2012.04.629
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Post hoc analysis of two Phase 3 pivotal trials (EMERALD 1,2) of
peginesatide vs epoetin for anemia due to chronic kidney disease in
hemodialysis patients on stable epoetin showed that for increasing doses of
baseline epoetin, relatively less peginesatide was needed to achieve similar
Hb levels (Fishbane et al, ASN 2011). Estimation of peginesatide should
therefore be dictated by underlying epoetin dose distribution rather than
total volume or mean epoetin dose in a population. This analysis compared
estimated peginesatide utilization for facilities using comparable levels of
epoetin.
Eight facilities from a large dialysis organization whose epoetin
utilization was within 71% of median utilization across all facilities from
Q4 2011 were compared. The label-speciﬁed dose conversion table was
used to convert weekly epoetin dose (deﬁned using all pt-months with Z1
dose) to monthly peginesatide dose for each facility
Comparison of total epoetin use (Q4 2011) from the 8 facilities showed
relative differences of o2% (range, 6.4-6.5M U). Facility utilization of post-
conversion peginesatide was estimated to range from 668-901 mg,
representing relative differences of up to 35% (Figure)
In contrast, calculations based on mean epoetin doses resulted in 41-
184% overestimation of peginesatide use.
Due to the nonlinear dose relationship between peginesatide and
epoetin, facilities with similar epoetin use (o2% relative difference) had up
to 35% difference in estimate of peginesatide use. For accurate estimation
of peginesatide utilization, it is important to base conversions on epoetin
dose distribution rather than mean epoetin dose.
http://dx.doi.org/10.1016/j.krcp.2012.04.630
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Many previous studies of renal transplant recipients have demonstrated
that weight gain post kidney transplantation (KT) is frequent and may
predispose to co morbidity. The aim of this prospective study was to
evaluate changes in body composition (BC) during the ﬁrst two years post
KT and to determine predictors of these changes, with a special focus on
pre KT parameters.
When listed for a KT, 41 patients (14 women - 27 men) were included
between 2007 and 2008 in a longitudinal study of evaluation of BC. Fat Free
Mass (FFM) and Fat Mass (FM) were estimated by Dual-energy X- ray
absorptiometry. At the same time, Extra Cellular Water (ECW) was
measured by bio impedance spectroscopy. Cellular Active Mass (CAM) was
deﬁned as FFM – ECW. Energy and protein intake (EI –PI), physical activity
(PA), biochemical and nutritional parameters were also recorded. Patients
were evaluated every 6 months before KT, and 15 days, 1, 3, 6, 12 and 24
months after KT. During the ﬁrst 2 years post KT, FM increase 0.09 kg/
month (p¼0.007), FFM by 0.06kg/month (p¼0.0556) and MCA by 0.04kg/
month (p¼0.04). Univariate analysis showed that during the ﬁrst 30 days
post KT, FFM is strongly inﬂuenced by male gender, higher BMI, higher
PIbefore KT, higher PA before KT and lower CRP post KT. During the ﬁrst
2 years, FFM evolution is associated with male gender, higher EI and PI post
KT. Early post KT evolution of FM is related to high BMI and high
cumulative dose of corticosteroids. Long term evolution is associated with
EI and use of corticosteroids. Pre KT EI and PI, as well as male gender and
BMI inﬂuenced signiﬁcantly the early evolution of MCA. In adjusted
analyses, BMI and gender remained independently associated with FM,
FFM and CAM. Furthermore, higher FFM level was associated with
higher EI.
We conﬁrm that successful KT is associated with BC modiﬁcations;
which can be detected very early post KT. These very early changes are
strongly associated with energy, protein intake and physical activity level
pre KT. Management of post KT weight gain should be anticipated with a
special care on nutritional intake and physical activity in patients waiting
kidney transplantation.
http://dx.doi.org/10.1016/j.krcp.2012.04.631
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Bio impedance spectroscopy (BIS) is widely used in pathological
situations to measure body composition. However, the results of BIS
validation with reference methods are still contradictory, especially in
medical situations where hydratation status is compromised. The aim of
this study was to evaluate the accuracy of BIS to estimate fat free mass
(FFM) and fat mass (FM) in dialysed patients using dual-energy X-ray
absorptiometry (DXA) as a reference compared to the results obtained in
the same patients two years after successful kidney transplantation.
When listed for a kidney grafting, 39 patients who consent were included
in a longitudinal study of evaluation of body composition (CORPOS). FFM
and FM were estimated by DXA and by BIS (Imp SFB7 Impedimed Pty Ltd.
Queensland, Australia), both performed successively the same day. These
measurements were repeated in the same patients 24 months after renal
transplantation.
DXA and BIS measures of FFM and FM were highly correlated in dialyzed
patients (DP) (respectively r¼0.909 po0.001 and r¼0.831 po0.001) and
kidney transplant recipients (KTR) (respectively r¼0.934 po0.001 and
r¼0.770 po0.001). The mean difference between DXA and BIS (Bland-
Altman analysis) for FFM estimation was smaller in KTR (-0.3 þ/- 4.9 vs 3.2
þ/- 4.5 in DP), whereas difference did not reach signiﬁcance for FM.
Differences between upper and lower limits are important in all groups: -5
to 15.5 kg for FFM in DP; -10.2 to 8.8 kg for FFM in KTR; -11.6 to 6.8 kg for
FM in DP and -9 to 14.9 kg for FM in KTR. Despite this individual
variability, the whole body composition evolution after kidney
transplantation is approached the same way by both methods.
DXA and BIS measurements were highly correlated in both DP and KTR.
However, the large individual differences demonstrated that single values
of FFM or FM may be interpreted carefully but BIS as DXA has ability to
evaluate changes in body composition over time in longitudinal studies.
http://dx.doi.org/10.1016/j.krcp.2012.04.632
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